Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Merseburger

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Der Urologe. Ausg. A|November 20, 2012
[Pathophysiology and therapy of castration-resistant prostate cancer]A S Merseburger, M A Kuczyk, J M Wolff
Der Urologe. Ausg. A|September 7, 2007
[Is there an indication for neoadjuvant or adjuvant systemic therapy in renal cell cancer?]C Doehn, A S Merseburger, D Jocham, et al.
Der Urologe. Ausg. A|June 17, 2016
[Communication preferences of patients with prostate cancer : Preferences regarding the communication of bad news of patients with prostate cancer in Germany-results of an anonymous patient survey]A S Merseburger, M W Kramer, K Scheithe, et al.
Der Urologe. Ausg. A|October 15, 2013
[Systemic therapy of metastatic bladder cancer.]M Retz, S C Schmid, M W Kramer, et al.
Der Urologe. Ausg. A|June 7, 2014
[Cross-sectional analysis of routine treatment for prostate cancer patients: CAPRIS - a healthcare research project of the IQUO]M Schulze, H Stiegler, C Thielecke, et al.
Aktuelle Urologie|July 28, 2009
[Anterior exenteration in the woman]A G Anastasiadis, A S Merseburger, M A Kuczyk, et al.
World Journal of Urology|April 4, 2019
The new ISUP 2014/WHO 2016 prostate cancer grade group system: first résumé 5 years after introduction and systemic review of the literatureA Offermann, M C Hupe, V Sailer, et al.
Aktuelle Urologie|February 7, 2015
[Castration resistant prostate cancer 2015]A S Merseburger, A Böker, M A Kuczyk, et al.
Aktuelle Urologie|June 17, 2015
[Neoadjuvant or Adjuvant Chemotherapy for Bladder Cancer?]M C Hupe, M W Kramer, M A Kuczyk, et al.
Der Urologe. Ausg. A|March 19, 2010
[Galectin expression in urological cancer. Diagnostic, prognostic and therapeutic potential]S Waalkes, A S Merseburger, A Simon, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Der Urologe. Ausg. A|November 20, 2012
[Pathophysiology and therapy of castration-resistant prostate cancer]A S Merseburger, M A Kuczyk, J M Wolff
Der Urologe. Ausg. A|September 7, 2007
[Is there an indication for neoadjuvant or adjuvant systemic therapy in renal cell cancer?]C Doehn, A S Merseburger, D Jocham, et al.
Der Urologe. Ausg. A|June 17, 2016
[Communication preferences of patients with prostate cancer : Preferences regarding the communication of bad news of patients with prostate cancer in Germany-results of an anonymous patient survey]A S Merseburger, M W Kramer, K Scheithe, et al.
Der Urologe. Ausg. A|October 15, 2013
[Systemic therapy of metastatic bladder cancer.]M Retz, S C Schmid, M W Kramer, et al.
Der Urologe. Ausg. A|June 7, 2014
[Cross-sectional analysis of routine treatment for prostate cancer patients: CAPRIS - a healthcare research project of the IQUO]M Schulze, H Stiegler, C Thielecke, et al.
Aktuelle Urologie|July 28, 2009
[Anterior exenteration in the woman]A G Anastasiadis, A S Merseburger, M A Kuczyk, et al.
World Journal of Urology|April 4, 2019
The new ISUP 2014/WHO 2016 prostate cancer grade group system: first résumé 5 years after introduction and systemic review of the literatureA Offermann, M C Hupe, V Sailer, et al.
Aktuelle Urologie|February 7, 2015
[Castration resistant prostate cancer 2015]A S Merseburger, A Böker, M A Kuczyk, et al.
Aktuelle Urologie|June 17, 2015
[Neoadjuvant or Adjuvant Chemotherapy for Bladder Cancer?]M C Hupe, M W Kramer, M A Kuczyk, et al.
Der Urologe. Ausg. A|March 19, 2010
[Galectin expression in urological cancer. Diagnostic, prognostic and therapeutic potential]S Waalkes, A S Merseburger, A Simon, et al.
Pageof 8